Andrew Sinclair - Jun 1, 2022 Form 4 Insider Report for SOLENO THERAPEUTICS INC (SLNO)

Role
Director
Signature
/s/ Anish Bhatnagar, Attorney-in-Fact
Stock symbol
SLNO
Transactions as of
Jun 1, 2022
Transactions value $
$0
Form type
4
Date filed
10/14/2022, 06:31 PM
Previous filing
Mar 31, 2022
Next filing
Jun 3, 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SLNO Stock option (right to buy) Award $0 +2.67K $0.00 2.67K Jun 1, 2022 Common Stock 2.67K $2.55 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The per share exercise price and number of shares subject to the option reflect the 1-for-15 reverse stock split effected August 26, 2022.
F2 The shares subject to the Option shall vest on the earlier of the twelve-month anniversary of June 1, 2022 or the day before the next annual stockholder meeting, subject to Reporting Person continuing to be a Service Provider through each such date.